Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Submucosal dexamethasone to improve inferior alveolar nerve block success in mandibular molars with symptomatic irreversible pulpitis
RBR-89495pkNot yet recruiting
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone, lidocaine, epinephrine and sodium chloride in irreversible pulpitis (2 arms), sponsored by Universidade Federal do Rio Grande do Sul. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
dexamethasonelidocaineepinephrinesodium chloride
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on RBR-89495pk.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-89495pk.